Event JSON
{
"id": "adfb5c622b60d16659636cb64ef9a6a5101816f4abec2d50136b51d950afb66b",
"pubkey": "e9d555fcc508b077f9adb908fb97770593291651d3c4ae96d8d9a04d2312ba7a",
"created_at": 1724234746,
"kind": 1,
"tags": [
[
"d",
"f70773e1-8adb-4bd9-82bb-b24ada303b7b"
],
[
"subject",
"Summary of Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program"
],
[
"r",
"https://layer3.news/api/public/publications/f70773e1-8adb-4bd9-82bb-b24ada303b7b"
],
[
"snaid",
"6edd3227-e00c-4e68-bc80-50c832580e7f"
],
[
"p",
"e9d555fcc508b077f9adb908fb97770593291651d3c4ae96d8d9a04d2312ba7a"
],
[
"p",
"b84f613c130f4cd316c9593bf9024eb6278ec137af90eff28033712bdda04ced"
],
[
"q",
"4da293e57c75fb1e10a37d2f2477d97db0ea36f4be921de068c84ff8be043957",
"wss://articles.layer3.news"
],
[
"e",
"4da293e57c75fb1e10a37d2f2477d97db0ea36f4be921de068c84ff8be043957",
"wss://articles.layer3.news",
"root"
]
],
"content": "Summary of Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program\nnostr:nevent1qqsymg5nu478t7c7zz3h6teywlvhmv82xm6taysaup5vsnlchczrj4czyzuy7cfuzv85e5cke9vnh7gzf6mz0rkpx7hepmljsqehz27a5pxw6qcyqqqqqqgrl4zly\n\nSesame, a health-care marketplace, has launched a clinical weight loss program that allows patients to access compounded versions of Novo Nordisk's Wegovy, a $1,000-per-month obesity drug, for $249 per month. The program aims to help patients safely access obesity and diabetes treatments amid supply shortages and offers a more affordable alternative to branded drugs.",
"sig": "0a2fdcc3307fdad20093d9ba8604891cdbd80060920133b29f3d38e479a060ddb5a2b7d57c268fe7462723316be521bbdbf6fd9c4b45a9159b97277d141bd615"
}
